( May 19, 2026, 11:56 AM EDT) -- BOSTON — A federal jury in Massachusetts on May 18 found Takeda Pharmaceuticals USA Inc. liable for $474.89 million in damages in a class action alleging that the pharmaceutical company violated federal and state antitrust laws by working with a competitor to delay the availability of a generic version of its drug to treat irritable bowel syndrome and chronic constipation....